|
PDE4D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.955530E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.370700E-04 |
| Normal-vs-Stage2 |
1.701160E-03 |
| Normal-vs-Stage3 |
5.91149999999985E-05 |
| Normal-vs-Stage4 |
2.840900E-04 |
| Stage1-vs-Stage2 |
5.484600E-01 |
| Stage1-vs-Stage3 |
1.317780E-01 |
| Stage1-vs-Stage4 |
3.714800E-01 |
| Stage2-vs-Stage3 |
9.309800E-02 |
| Stage2-vs-Stage4 |
2.337600E-01 |
| Stage3-vs-Stage4 |
9.748200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.043790E-04 |
| Normal-vs-AfricanAmerican |
2.606300E-02 |
| Normal-vs-Asian |
3.585200E-04 |
| Caucasian-vs-AfricanAmerican |
2.173400E-01 |
| Caucasian-vs-Asian |
7.873000E-01 |
| AfricanAmerican-vs-Asian |
2.240000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.6608000000049E-05 |
| Normal-vs-Female |
4.162400E-04 |
| Male-vs-Female |
1.850040E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.029670E-04 |
| Normal-vs-Age(41-60Yrs) |
4.390800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.609290E-04 |
| Normal-vs-Age(81-100Yrs) |
3.955600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.554600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.785840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.664200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.680200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.7025999994641E-07 |
| Classical-VS-Follicular |
3.524800E-03 |
| Classical-VS-Other |
8.069600E-01 |
| Classical-VS-Normal |
1.165420E-04 |
| Tall-VS-Follicular |
1.24749999996787E-07 |
| Tall-VS-Other |
3.085200E-01 |
| Tall-VS-Normal |
2.73099999947846E-07 |
| Follicular-VS-Other |
2.943600E-01 |
| Follicular-VS-Normal |
3.116200E-02 |
| Other-VS-Normal |
7.357300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.048600E-04 |
| Normal-vs-N1 |
1.423670E-04 |
| N0-vs-N1 |
4.548000E-01 |
|
|
